UBS Group’s Adient ADNT Stock Holding History

UBS Group’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-41,800	Closed	-$1.01M	–	10441
2025 Q3	$1.01M	Hold	41,800	–	–	﹤0.01%	5567
2025 Q2	$813K	Buy	+41,800	New	+$618K	﹤0.01%	5615
2021 Q1	–	Sell	-80,000	Closed	-$2.78M	–	8925
2020 Q4	$2.78M	Buy	80,000 +40,000	+100%	+$1.13M	﹤0.01%	3066
2020 Q3	$693K	Hold	40,000	–	–	﹤0.01%	3916
2020 Q2	$657K	Hold	40,000	–	–	﹤0.01%	3913
2020 Q1	$363K	Buy	40,000 +32,500	+433%	+$655K	﹤0.01%	4252
2019 Q4	$159K	Sell	7,500 -123,200	-94%	-$2.73M	﹤0.01%	5740
2019 Q3	$3M	Buy	130,700 +50,000	+62%	+$1.14M	﹤0.01%	2890
2019 Q2	$1.96M	Buy	+80,700	New	+$1.66M	﹤0.01%	3167

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's ADNT Position: Q1 2026 in Review

UBS Group increased its Adient (ADNT) stake by 4.2% in Q1 2026, buying an estimated $1.73M and bringing the position to 1,926,609 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1892.

UBS Group first reported a position in ADNT in Q4 2016 and has held it in 38 quarters since. The position peaked at $77.2M in Q1 2018. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

UBS Group held 1,926,609 shares of Adient worth $38.9M as of Q1 2026.
UBS Group bought 77,919 Adient shares in Q1 2026, an estimated $1.73M.
Adient made up 0.01% of UBS Group's portfolio in Q1 2026, its #1892 holding.
UBS Group first reported a position in Adient in Q4 2016 and has held it in 38 quarters since.
UBS Group's Adient position peaked at $77.2M in Q1 2018.
287 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.